Abstract
The history of Hodgkin's disease is one of the most exciting stories in medicine. The disorder accounts for about 1% of all cancers and is curable in 85 to 95% of cases, depending on its stage — whether it is localized or disseminated. Indeed, the article by Fermé et al.1 in this issue of the Journal reports on 10-year survival estimates of 97% for patients with early-stage disease.In 1832, in an article entitled “On Some Morbid Appearances of the Absorbent Glands and Spleen,”2 Thomas Hodgkin discussed six patients with symptoms that differed from those associated with inflammation, tuberculosis, and . . .

This publication has 10 references indexed in Scilit: